FDA Orange Book Listing of System Claims Clarified by Recent Pharmaceutical Case
By Emily Grigas and Richard Kurz – March 16, 2023 | The decision demonstrates that whether a patent may be eligible for Orange Book listing requires a case-by-case analysis.